Nasus Pharma (NYSEAMERICAN:NSRX) Issues Earnings Results

Nasus Pharma (NYSEAMERICAN:NSRXGet Free Report) posted its quarterly earnings data on Monday. The company reported ($0.27) EPS for the quarter, FiscalAI reports.

Nasus Pharma Stock Down 1.4%

NSRX stock opened at $3.65 on Wednesday. The business has a 50 day moving average of $3.22 and a 200-day moving average of $3.50. Nasus Pharma has a 12-month low of $1.98 and a 12-month high of $9.99.

Nasus Pharma Company Profile

(Get Free Report)

Nasus Pharma Ltd. is a clinical-stage pharmaceutical company focused on the development of innovative intranasal products to treat emergency medical conditions. Nasus Pharma Ltd. is based in TEL AVIV, Israel.

Further Reading

Receive News & Ratings for Nasus Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nasus Pharma and related companies with MarketBeat.com's FREE daily email newsletter.